A SINGLE-ARM, OPEN-LABEL, LONG-TERM EFFICACY AND SAFETY STUDY OF SUBCUTANEOUS ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA

被引：0
|
作者：
Grainger, J. [1 ]
Bussel, J. [2 ]
Cooper, N. [3 ]
Tarantino, M. [4 ]
Blanchette, V. [5 ]
Despotovic, J. [6 ]
Maschan, A. [7 ]
Carpenter, N. [8 ]
Eisen, M. [9 ]
Mehta, B. [9 ]
机构：
[1] Univ Manchester, Manchester, Lancs, England
[2] Weill Cornell Med, New York, NY USA
[3] Imperial Coll, Hammersmith Hosp, London, England
[4] Bleeding & Clotting Disorders Inst, Peoria, IL USA
[5] Hosp Sick Children, Toronto, ON, Canada
[6] Texas Childrens Hematol Ctr, Houston, TX USA
[7] Fed Res Ctr Pediat Hematol Oncol & Immunol, Moscow, Russia
[8] Amgen Ltd, Uxbridge, Middx, England
[9] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P367
引用
收藏
页码：124 / 125
页数：2
相关论文
共 50 条
  • [21] Long-Term Efficacy and Safety of Romiplostim for the Treatment of Patients with Chronic Immune Thrombocytopenia (ITP): 5-Year Update From An Open-Label Extension Study
    Bussel, James B.
    Kuter, David J.
    Newland, Adrian
    de Wolf, Joost T. M.
    Wasser, Jeffrey
    Chang, Paul
    Nie, Kun
    Berger, Dietmar
    BLOOD, 2009, 114 (22) : 285 - 285
  • [22] EVALUATION OF EFFICACY AND SAFETY OF LONG-TERM ROMIPLOSTIM TREATMENT FOR PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP) ENROLLED IN AN OPEN-LABEL EXTENSION STUDY: A PATIENT COHORT-ANALYSIS
    Kuter, J.
    Newland, A.
    Bussel, J.
    Wasser, J.
    Nie, K.
    Jun, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 76 - 76
  • [23] SAFETY AND EFFICACY OF LONG-TERM OPEN-LABEL DOSING OF ROMIPLOSTIM, ATHROMBOPOIETIN (TPO) - RECEPTOR AGONIST, IN THROMBOCYTOPENIC PEDIATRIC PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP) IN AN EXTENSION STUDY
    Bussel, James
    Tarantino, Michael
    Geddis, Amy
    Guerrera, Michael
    Ikeda, Alan
    Nie, Kun
    Franklin, Janet
    Eisen, Melissa
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 48 - 48
  • [24] Long-term safety of nebivolol and valsartan combination therapy in patients with hypertension: an open-label, single-arm, multicenter study
    Neutel, Joel M.
    Giles, Thomas D.
    Punzi, Henry
    Weiss, Robert J.
    Li, Huiling
    Finck, Amy
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2014, 8 (12) : 915 - 920
  • [25] An Open-Label, Single-Arm, Pilot Intervention Study to Assess the Efficacy and Safety of Apixaban in Heparin-Induced Thrombocytopenia
    Farasatinasab, Maryam
    Balouchzehi, Saeedeh
    Moghaddam, Omid Moradi
    Ansarinejad, Nafiseh
    Mohammadi, Mahmonir
    Nasiripour, Somayyeh
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (11): : 1379 - 1384
  • [26] SAFETY AND EFFICACY OF LONG-TERM OPEN-LABEL DOSING OF ROMIPLOSTIM, A THROMBOPOIETIN (TPO)-RECEPTOR-AGONIST, IN THROMBOCYTOPENIC PEDIATRIC PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP) IN AN EXTENSION STUDY
    Tarantino, Michael
    Bussel, James
    Geddis, Amy
    Guerrera, Michael
    Ikeda, Alan
    Nie, Kun
    Eisen, Melissa
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S46 - S46
  • [27] LONG-TERM USE OF THE THROMBOPOETIN RECEPTOR AGONIST ROMIPLOSTIM IN CHILDREN WITH CHRONIC/REFRACTORY IMMUNE THROMBOCYTOPENIA (ITP) IN AN OPEN-LABEL EXTENSION STUDY (OLE)
    Bussel, James
    Buchanan, George
    Gnarra, David
    Ho, Richard
    Nie, Kun
    Eisen, Melissa
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S34 - S34
  • [28] Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
    Kuter, David J.
    Bussel, James B.
    Newland, Adrian
    Baker, Ross I.
    Lyons, Roger M.
    Wasser, Jeffrey
    Viallard, Jean-Francois
    Macik, Gail
    Rummel, Mathias
    Nie, Kun
    Jun, Susie
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (03) : 411 - 423
  • [29] Long-Term Assessment of Topiramate for Epilepsy An Open-Label, Single-Arm, Multicentre, Prospective Study in a Naturalistic Setting
    Hufnagel, Andreas
    Kowalik, Andreas
    Rettig, Klaus
    Schreiner, Andreas
    Schaeuble, Barbara
    CLINICAL DRUG INVESTIGATION, 2011, 31 (11) : 779 - 790
  • [30] Long-Term Assessment of Topiramate for EpilepsyAn Open-Label, Single-Arm, Multicentre, Prospective Study in a Naturalistic Setting
    Andreas Hufnagel
    Andreas Kowalik
    Klaus Rettig
    Andreas Schreiner
    Barbara Schäuble
    Clinical Drug Investigation, 2011, 31 : 779 - 790
12345